Cite
Kondo M, Kamiya H, Himeno T, et al. Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. J Diabetes Investig. 2014;6(2):140-9doi: 10.1111/jdi.12272.
Kondo, M., Kamiya, H., Himeno, T., Naruse, K., Nakashima, E., Watarai, A., Shibata, T., Tosaki, T., Kato, J., Okawa, T., Hamada, Y., Isobe, K., Oiso, Y., & Nakamura, J. (2015). Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. Journal of diabetes investigation, 6(2), 140-9. https://doi.org/10.1111/jdi.12272
Kondo, Masaki, et al. "Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes." Journal of diabetes investigation vol. 6,2 (2015): 140-9. doi: https://doi.org/10.1111/jdi.12272
Kondo M, Kamiya H, Himeno T, Naruse K, Nakashima E, Watarai A, Shibata T, Tosaki T, Kato J, Okawa T, Hamada Y, Isobe K, Oiso Y, Nakamura J. Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. J Diabetes Investig. 2015 Mar;6(2):140-9. doi: 10.1111/jdi.12272. Epub 2014 Sep 11. PMID: 25802721; PMCID: PMC4364848.
Copy
Download .nbib